Key result
A high SYNTAX score II (>26) was associated with a higher 1-year rate of major adverse cardiac events compared to intermediate and low scores.
Why the study?
Does the SYNTAX score II predict 1-year major adverse cardiac events better than other risk scores in patients with STEMI undergoing primary PCI?
Cohort (n=477)
Does the SYNTAX score II predict 1-year major adverse cardiac events better than other risk scores in patients with STEMI undergoing primary PCI?
The SYNTAX score II is an independent predictor of 1-year MACE in STEMI patients undergoing primary PCI and outperforms anatomical SYNTAX, Logistic Clinical SYNTAX, and GRACE scores.
Answers are grounded in this paper and cite their sources.
May refine prognostication after primary PCI; leaves open whether SYNTAX II outperforms other scores prospectively.
OBJECTIVE: This study aimed to investigate the predictive effect of SYNTAX score II (SS-II) for the 1-year outcome in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention and whether SS-II improves the ability of anatomical and Logistic Clinical SYNTAX score and Global Registry of Acute Coronary Events to predict major adverse cardiac events (MACE). BACKGROUND: SS-II can predict 1-year outcomes in patients with complex coronary artery disease. However, the prognostic value of SS-II for patients undergoing primary percutaneous coronary intervention remains unclear. MATERIALS AND METHODS: A total of 477 patients were divided into three groups on the basis of SS-II [SS-II low tertile <20 (n=161), 20 ≤SS-II intermediate tertile ≤26 (n=145), and SS-II high tertile >26 (n=171)]. Kaplan-Meier methods were used to compare the MACE at the 1-year follow-up. RESULTS: MACE was highest in the SS-II high tertile (21.1 vs. 10.3 vs. 5.5%, P<0.001), including all-cause mortality (11.7 vs. 4.1 vs. 2.5%, P=0.001), target vessel revascularization (7.6 vs. 4.1 vs. 1.8%, P=0.037), and recurrent MI (5.8 vs. 2.1 vs. 1.2%, P=0.035), compared with SS-II intermediate and low tertiles. In Cox multivariable analysis, SS-II was an independent predictor for MACE at 1 year. The receiver operating characteristic curve showed that SS-II had 60% sensitivity and 78% specificity for predicting 1-year MACE as a cut-off value of 27.5. The respective C-statistics of SS-II, anatomical, and Logistic Clinical SYNTAX score and Global Registry of Acute Coronary Events for MACE were 0.726, 0.587, 0.684, and 0.628 (P<0.05). CONCLUSION: SS-II can predict 1-year clinical outcomes in patients with ST-segment elevation myocardial infarction and has an improved ability to predict MACE.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2016) conducted a cohort in ST-segment elevation myocardial infarction (n=477). High SYNTAX score II (>26) vs. Intermediate (20-26) and low (<20) SYNTAX score II was evaluated on Major adverse cardiac events (MACE) (p=<0.001). A high SYNTAX score II (>26) was associated with a higher 1-year rate of major adverse cardiac events compared to intermediate and low scores.
Synapse has enriched 10 related papers. Consider them for comparative context: